{"id":"https://openalex.org/W2563868030","doi":"https://doi.org/10.18632/oncotarget.14011","title":"Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer","display_name":"Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer","publication_year":2016,"publication_date":"2016-12-17","ids":{"openalex":"https://openalex.org/W2563868030","doi":"https://doi.org/10.18632/oncotarget.14011","mag":"2563868030","pmid":"https://pubmed.ncbi.nlm.nih.gov/28002809","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5351612"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.14011","doi":"https://doi.org/10.18632/oncotarget.14011","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.14011","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=14011&path%5B%5D=44654","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=14011&path%5B%5D=44654","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111733547","display_name":"Paul M Wilkerson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Paul M Wilkerson","raw_affiliation_strings":["The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020607837","display_name":"Konstantin Johannes Dedes","orcid":"https://orcid.org/0000-0002-8741-9319","observed_orcids":["https://orcid.org/0000-0002-8741-9319"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH","GB"],"is_corresponding":true,"raw_author_name":"Konstantin J Dedes","raw_affiliation_strings":["Department of Gynaecology, University Hospital of Zurich, 8091 Zurich, CH","The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynaecology, University Hospital of Zurich, 8091 Zurich, CH","institution_ids":["https://openalex.org/I4210100468"]},{"raw_affiliation_string":"The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089104401","display_name":"Eleftherios Pierre Samartzis","orcid":"https://orcid.org/0000-0002-8246-5842","observed_orcids":["https://orcid.org/0000-0002-8246-5842"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Eleftherios Pierre Samartzis","raw_affiliation_strings":["Department of Gynaecology, University Hospital of Zurich, 8091 Zurich, CH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynaecology, University Hospital of Zurich, 8091 Zurich, CH","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029100909","display_name":"Ioannis Dedes","orcid":"https://orcid.org/0000-0001-7265-4765","observed_orcids":["https://orcid.org/0000-0001-7265-4765"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ioannis Dedes","raw_affiliation_strings":["Department of Gynaecology, University Hospital of Zurich, 8091 Zurich, CH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gynaecology, University Hospital of Zurich, 8091 Zurich, CH","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111839800","display_name":"Maryou B.K. Lambros","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH","GB"],"is_corresponding":false,"raw_author_name":"Maryou B Lambros","raw_affiliation_strings":["The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","Department of Gynaecology, University Hospital of Zurich, 8091 Zurich, CH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"Department of Gynaecology, University Hospital of Zurich, 8091 Zurich, CH","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057324933","display_name":"Rachael Natrajan","orcid":"https://orcid.org/0000-0002-9987-2946","observed_orcids":["https://orcid.org/0000-0002-9987-2946"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachael Natrajan","raw_affiliation_strings":["The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Arnaud Gauthier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Arnaud Gauthier","raw_affiliation_strings":["The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051087530","display_name":"Salvatore Piscuoglio","orcid":"https://orcid.org/0000-0003-2686-2939","observed_orcids":["https://orcid.org/0000-0003-2686-2939"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Salvatore Piscuoglio","raw_affiliation_strings":["Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062179325","display_name":"Chantal T\u00f6pfer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chantal T\u00f6pfer","raw_affiliation_strings":["The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078890471","display_name":"Vesna Vukovic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Vesna Vukovic","raw_affiliation_strings":["The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017556707","display_name":"Frances M Daley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Frances Daley","raw_affiliation_strings":["The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040506127","display_name":"Britta Weigelt","orcid":"https://orcid.org/0000-0001-9927-1270","observed_orcids":["https://orcid.org/0000-0001-9927-1270"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Britta Weigelt","raw_affiliation_strings":["Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077235697","display_name":"Jorge Sergio Reis-Filho","orcid":"https://orcid.org/0000-0003-2969-3173","observed_orcids":["https://orcid.org/0000-0003-2969-3173"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Jorge S Reis-Filho","raw_affiliation_strings":["Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA","The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5020607837","https://openalex.org/A5111733547"],"corresponding_institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210100468"],"apc_list":null,"apc_paid":null,"fwci":1.2175,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.8171572,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"8","issue":"4","first_page":"6057","last_page":"6066"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-clear-cell-carcinoma","display_name":"ovarian clear cell carcinoma","score":0.902999997138977},{"id":"https://openalex.org/keywords/talazoparib","display_name":"talazoparib","score":0.9490000009536743},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.7889999747276306},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.5630000233650208},{"id":"https://openalex.org/keywords/cisplatin-sensitivity","display_name":"cisplatin sensitivity","score":0.8899999856948853},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.753000020980835},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.9919999837875366},{"id":"https://openalex.org/keywords/mre11","display_name":"MRE11","score":0.9810000061988831},{"id":"https://openalex.org/keywords/rad51-foci","display_name":"RAD51 foci","score":0.8679999709129333},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.7070000171661377},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.5669999718666077},{"id":"https://openalex.org/keywords/parp-inhibitor-resistance","display_name":"PARP inhibitor resistance","score":0.49300000071525574}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.809335470199585},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5457474589347839},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5228607654571533},{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.5221105813980103},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5113717913627625},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5022907257080078},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4904908537864685},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.4899069666862488},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.48194360733032227},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.4533507227897644},{"id":"https://openalex.org/C2781199814","wikidata":"https://www.wikidata.org/wiki/Q18556242","display_name":"Clear cell carcinoma","level":3,"score":0.4117836058139801},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4110245406627655},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32910382747650146},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.2878098487854004},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.2276763617992401},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22577565908432007},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1732640266418457},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.1410796046257019},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.10803729295730591},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07634013891220093},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000076228","descriptor_name":"MRE11 Homologue Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004260","descriptor_name":"DNA Repair","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019313","descriptor_name":"BRCA1 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D024682","descriptor_name":"BRCA2 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D046888","descriptor_name":"Tissue Array Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051059","descriptor_name":"PTEN Phosphohydrolase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053903","descriptor_name":"DNA Breaks, Double-Stranded","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.18632/oncotarget.14011","doi":"https://doi.org/10.18632/oncotarget.14011","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.14011","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=14011&path%5B%5D=44654","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5351612","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5351612","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmid:28002809","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28002809","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"pmh:oai:www.zora.uzh.ch:132799","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/id/eprint/132799/1/14011-209092-4-PB.pdf","pdf_url":"https://www.zora.uzh.ch/id/eprint/132799/1/14011-209092-4-PB.pdf","source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Wilkerson, Paul M; Dedes, Konstantin J; Samartzis, Eleftherios Pierre; Dedes, Ioannis; Lambros, Maryou B; Natrajan, Rachael; Gauthier, Arnaud; Piscuoglio, Salvatore; T\u00f6pfer, Chantal; Vukovic, Vesna; Daley, Frances; Weigelt, Britta; Reis-Filho, Jorge S (2017). Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer. OncoTarget, 8(4):6057-6066.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/126810","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/126810","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Wilkerson, P. M., Dedes, K. J., Samartzis, E. P., Dedes, I., Lambros, M. B., Natrajan, R., Gauthier, A., Piscuoglio, S., T\u00f6pfer, C., Vukovic, V., Daley, F., Weigelt, B., & Reis-Filho, J. S. (2017). Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer. OncoTarget, 8, 6057\u20136066. https://doi.org/10.18632/oncotarget.14011","raw_type":"Journal Article"},{"id":"doi:10.5167/uzh-132799","doi":"https://doi.org/10.5167/uzh-132799","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-132799","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.14011","doi":"https://doi.org/10.18632/oncotarget.14011","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.14011","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=14011&path%5B%5D=44654","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320320924","display_name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","ror":"https://ror.org/00yjd3n13"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2563868030.pdf","grobid_xml":"https://content.openalex.org/works/W2563868030.grobid-xml"},"referenced_works_count":53,"referenced_works":["https://openalex.org/W1774317821","https://openalex.org/W1892496998","https://openalex.org/W1971954823","https://openalex.org/W1973268287","https://openalex.org/W1975141727","https://openalex.org/W1975307022","https://openalex.org/W1991900520","https://openalex.org/W1993685841","https://openalex.org/W1999659306","https://openalex.org/W2002419036","https://openalex.org/W2002962154","https://openalex.org/W2003626435","https://openalex.org/W2004144597","https://openalex.org/W2012410089","https://openalex.org/W2025287967","https://openalex.org/W2032537938","https://openalex.org/W2033816200","https://openalex.org/W2044271955","https://openalex.org/W2045065956","https://openalex.org/W2048677309","https://openalex.org/W2049524122","https://openalex.org/W2051930220","https://openalex.org/W2054388774","https://openalex.org/W2064628234","https://openalex.org/W2065849886","https://openalex.org/W2072981858","https://openalex.org/W2096389012","https://openalex.org/W2106893529","https://openalex.org/W2109001339","https://openalex.org/W2110017381","https://openalex.org/W2111437716","https://openalex.org/W2114725617","https://openalex.org/W2117964602","https://openalex.org/W2121415861","https://openalex.org/W2124395452","https://openalex.org/W2129315871","https://openalex.org/W2135195813","https://openalex.org/W2137760882","https://openalex.org/W2142658272","https://openalex.org/W2142795777","https://openalex.org/W2143219457","https://openalex.org/W2147154862","https://openalex.org/W2148720931","https://openalex.org/W2151860429","https://openalex.org/W2154527822","https://openalex.org/W2161405893","https://openalex.org/W2161566038","https://openalex.org/W2163476499","https://openalex.org/W2166541695","https://openalex.org/W2169228223","https://openalex.org/W2171972386","https://openalex.org/W2216554257","https://openalex.org/W3093265161"],"related_works":["https://openalex.org/W2319915142","https://openalex.org/W3208155477","https://openalex.org/W4378676313","https://openalex.org/W7065310040","https://openalex.org/W3038897270","https://openalex.org/W2760794406","https://openalex.org/W7148650969","https://openalex.org/W3042018995","https://openalex.org/W4399586505","https://openalex.org/W4295817698"],"abstract_inverted_index":{"//":[0],"Paul":[1],"M":[2],"Wilkerson":[3],"1,":[4,10,59],"*":[5,12,101],",":[6,13,18,22,27,31,35,39,43,47,51,55,335],"Konstantin":[7,116],"J":[8,117],"Dedes":[9,20],"2,":[11],"Eleftherios":[14],"Pierre":[15],"Samartzis":[16],"2":[17,21,76],"Ioannis":[19],"Maryou":[23],"B":[24],"Lambros":[25],"1":[26,30,34,42,46,50,61],"Rachael":[28],"Natrajan":[29],"Arnaud":[32],"Gauthier":[33],"Salvatore":[36],"Piscuoglio":[37],"3":[38,54,60,87],"Chantal":[40],"T\u00f6pfer":[41],"Vesna":[44],"Vukovic":[45],"Frances":[48],"Daley":[49],"Britta":[52],"Weigelt":[53],"Jorge":[56,111],"S":[57,112],"Reis-Filho":[58],"The":[62,177],"Breakthrough":[63],"Breast":[64],"Cancer":[65,70,94],"Research":[66],"Centre,":[67],"Institute":[68],"of":[69,78,82,89,149,163,180,211,219,240,251,255,264,305,312,320,325,357,370],"Research,":[71],"London,":[72],"SW3":[73],"6JB,":[74],"UK":[75],"Department":[77,88],"Gynaecology,":[79],"University":[80],"Hospital":[81],"Zurich,":[83,85],"8091":[84],"CH":[86],"Pathology,":[90],"Memorial":[91],"Sloan":[92],"Kettering":[93],"Center,":[95],"New":[96],"York,":[97],"NY":[98],"10065,":[99],"USA":[100],"These":[102,349],"authors":[103],"contributed":[104],"equally":[105],"to":[106,170,193,269,330],"this":[107],"work":[108],"Correspondence":[109],"to:":[110],"Reis-Filho,":[113],"email:":[114,119],"reisfilj@mskcc.org":[115],"Dedes,":[118],"konstantin.dedes@usz.ch":[120],"Keywords:":[121],"ovarian":[122,150],"clear":[123,151],"cell":[124,152,183,275,296],"carcinoma,":[125],"homologous":[126,158],"recombination,":[127],"PTEN,":[128],"PARP":[129,173,197,331,361],"inhibitors":[130,362],"Received:":[131],"July":[132],"24,":[133],"2015":[134],"Accepted:":[135],"December":[136,140],"10,":[137],"2016":[138,142],"Published:":[139],"17,":[141],"ABSTRACT":[143],"Purpose:":[144],"To":[145],"determine":[146],"if":[147],"models":[148],"carcinomas":[153],"(OCCCs)":[154],"harbouring":[155],"defects":[156,342],"in":[157,248,317,333,367],"recombination":[159],"(HR)":[160],"DNA":[161,252],"repair":[162],"double":[164],"strand":[165],"breaks":[166],"(DSBs)":[167],"are":[168,328],"sensitive":[169,329],"cisplatin":[171,194],"and/or":[172],"inhibition.":[174],"Experimental":[175],"Design:":[176],"HR":[178,203,256,341,358],"status":[179],"12":[181],"OCCC":[182,229,241,259,274,326],"lines":[184,276,297],"was":[185,200,213,230,315],"determined":[186],"using":[187,235],"RAD51/\u03b3H2AX":[188],"foci":[189,246,347],"formation":[190,247],"assays.":[191],"Sensitivity":[192],"and":[195,208,301,360],"the":[196,249,262,295,355],"inhibitor":[198],"BMN-673":[199,220,271],"correlated":[201],"with":[202,261],"status.":[204],"BRCA1,":[205],"BRCA2,":[206],"MRE11":[207],"PTEN":[209,233,306,313],"loss":[210,304,311],"expression":[212,234,314],"investigated":[214],"as":[215,343,363],"a":[216,352,364,368],"potential":[217],"determinant":[218],"sensitivity.":[221],"A":[222,238,323],"tissue":[223],"microarray":[224],"containing":[225],"50":[226],"consecutive":[227],"primary":[228,309],"assessed":[231],"for":[232,354],"immunohistochemistry.":[236],"Results:":[237],"subset":[239,324,369],"cells":[242,327],"displayed":[243],"reduced":[244],"RAD51":[245],"presence":[250],"DSBs,":[253],"suggestive":[254],"defects.":[257],"HR-defective":[258],"cells,":[260],"exception":[263],"KOC-7c,":[265,302],"had":[266],"higher":[267],"sensitivity":[268],"cisplatin/":[270],"than":[272],"HR-competent":[273],"(Log10":[277],"SF50":[278],"\u20139.4":[279],"(SD":[280,285],"+/\u2212":[281,286],"0.29)":[282],"vs":[283],"\u20138.1":[284],"0.35),":[287],"mean":[288],"difference":[289],"1.3,":[290],"p":[291],"<":[292],"0.01).":[293],"Of":[294],"studied,":[298],"two,":[299],"TOV-21G":[300],"showed":[303],"expression.":[307],"In":[308],"OCCCs,":[310],"observed":[316],"10%":[318],"(5/49)":[319],"cases.":[321],"Conclusions:":[322],"inhibition":[332],"vitro":[334],"which":[336],"can":[337],"be":[338],"predicted":[339],"by":[340,345],"defined":[344],"\u03b3H2AX/RAD51":[346],"formation.":[348],"results":[350],"provide":[351],"rationale":[353],"testing":[356],"deficiency":[359],"targeted":[365],"therapy":[366],"OCCCs.":[371]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-01-06T00:00:00"}